Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05903326 · ClinicalTrials.gov registry record
Dexmedetomidine as a Sole Premedication for BMT Placement
A clinical trial, sponsored by Nemours Children's Clinic.
- Completed
- Registry status
- 276
- Enrollment target
NCT05903326 is a clinical trial that has completed, run by Nemours Children's Clinic. The registered enrollment target is 276 participants.
The verdict
NCT05903326 has completed, sponsored by Nemours Children's Clinic.
- COMPLETED
- Registry status
- 276 participants
- Enrollment target
Study Summary
There is very little evidence or research documenting any single method of sedation/analgesia for myringotomy tube (BMT) placement as being more effective than others. This was a retrospective chart review conducted to determine if there were significant differences in efficacy of administered pre-operative Midazolam and Intraoperative IM Ketorolac (traditional) vs. pre-operative Dexmedetomidine alone for pain and emergence delirium management of children undergoing placement of BMTs. The current protocol was changed under the direction of anesthesia and team members who wanted to see what the outcomes of the new management plan were. The plan was a prospective chart review and for this project, 276 patient charts were reviewed, 154 patients received traditional anesthesia treatment and 122 received Precedex. Data analysis indicated that the patients who had received Dexmedetomidine had significantly higher FLACC scores (meaning better pain control) than those who received the traditional therapy. There was no difference in emergence delirium between the two groups.
Interventions
- OTHER Dexmedetomidine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 276 participants |
| Start Date | 2022-02-11 |
| Est. Completion | 2023-02-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05903326
The ClinicalTrials.gov registry entry for NCT05903326 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 276 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Nemours Children's Clinic, which has 108 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Dexmedetomidine is the first listed.
NCT05903326 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05903326 about?
NCT05903326 is a clinical study titled "Dexmedetomidine as a Sole Premedication for BMT Placement". There is very little evidence or research documenting any single method of sedation/analgesia for myringotomy tube (BMT) placement as being more effective than others. This was a retrospective chart review conducted to determine if there were significant differences in efficacy of administered pre-o...
What is the current status of trial NCT05903326?
This trial is currently completed. The enrollment target is 276 participants. The study started on 2022-02-11. Estimated completion is 2023-02-03.
What interventions are being tested in trial NCT05903326?
The interventions under investigation include: Dexmedetomidine (OTHER).
Who is sponsoring clinical trial NCT05903326?
This trial is sponsored by Nemours Children's Clinic, which has 108 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.